Menopause in India: What Is Perimenopause, What Are the Symptoms, and What Actually Helps

The average Indian woman reaches menopause 2–3 years earlier than her Western counterpart — yet perimenopause is dramatically underrecognised in Indian clinical practice. Dr. Neha Sain explains what is happening hormonally, what symptoms to expect, and which treatments have real evidence behind them.

The word "menopause" arrives in a consultation in one of two ways. Either a woman in her late forties comes in having connected the dots between her symptoms and her age, or a woman in her early forties comes in with a cluster of symptoms she has been attributing to stress, thyroid problems, or simply getting older — and together we work out that perimenopause began months or even years before she recognised it. The second scenario is more common than it should be, and it reflects a gap in how openly and accurately this transition is discussed in Indian healthcare settings.

Let me lay out what is actually happening, what to expect, and what the evidence says about managing it.

The Language: Perimenopause, Menopause, and Postmenopause

These three words describe different phases of the same biological transition, and they are frequently confused.

Menopause is technically a single point in time — the moment at which 12 consecutive months have passed without a menstrual period, with no other medical explanation. In India, the average age of natural menopause is approximately 46 to 47 years, which is 2 to 3 years earlier than the average in Western populations. This difference is attributed to a combination of nutritional, genetic, and body composition factors.

Perimenopause is the transitional phase that precedes that final period — it typically begins 4 to 10 years beforehand. This is when ovarian hormone production becomes increasingly irregular. Your cycles may shorten or lengthen unpredictably. Ovulation may occur in some cycles but not others. Oestrogen and progesterone levels fluctuate dramatically — sometimes from week to week — which is precisely why the symptoms of perimenopause can feel so erratic.

Postmenopause refers to all the years after that 12-month mark — which, for most Indian women today, will span 30 or more years of life.

The Full Range of Symptoms

The two symptoms most commonly associated with menopause are hot flushes and irregular periods. But the picture is wider than that.

Vasomotor symptoms (hot flushes and night sweats): These affect approximately 70–80% of women during the transition. A hot flush is a sudden wave of heat — typically beginning in the chest and face — lasting a few minutes, often with visible flushing and sweating, sometimes followed by chills. Night sweats are the nocturnal equivalent and frequently devastate sleep quality. They are caused by the hypothalamus — your brain's thermostat — becoming dysregulated as oestrogen declines. Severity varies enormously between women.

Menstrual changes: In perimenopause, cycles often shorten first — some women notice their previously reliable 28-day cycle compressing to 24 or 25 days — before becoming unpredictable and eventually less frequent. Bleeding may be heavier during this transition before tapering. Any very heavy bleeding, bleeding after intercourse, or bleeding that occurs after more than a year without a period should always be investigated — these are not automatically attributable to menopause.

Sleep disruption: Many women report significant deterioration in sleep quality during perimenopause, beyond what can be attributed to night sweats alone. Oestrogen and progesterone both have sleep-modulating effects, and their decline alters sleep architecture directly.

Mood and cognitive changes: Low mood, irritability, and anxiety are genuinely more prevalent during the menopausal transition. There is substantial neurological evidence that the perimenopausal period represents a window of increased vulnerability to depression, even in women with no prior psychiatric history. Difficulty with concentration and word-finding — colloquially called "brain fog" — is also widely reported and tends to improve in the years following menopause.

Genitourinary syndrome: The decline in oestrogen causes the vaginal and urethral tissues to thin and lose elasticity — a condition called genitourinary syndrome of menopause (GSM). Symptoms include vaginal dryness, pain or discomfort during sex, increased urinary frequency, and greater susceptibility to urinary tract infections. This is the symptom set women are often most reluctant to raise, and the one for which several highly effective treatments are available.

Bone and cardiovascular health: Oestrogen has a protective effect on bone density and cardiovascular function. The years immediately after menopause represent the period of fastest bone loss in a woman's lifetime — roughly 2–3% per year for the first 5 to 10 years. In India, where baseline calcium and vitamin D deficiency is already widespread, this carries real significance. Women who reach menopause before 45 carry a higher long-term cardiovascular and osteoporosis risk.

Diagnosing Menopause

In women over 45 with typical symptoms, menopause is a clinical diagnosis — no blood tests are required. FSH can be measured if there is diagnostic uncertainty, but it fluctuates significantly during perimenopause and a single result can be misleading.

For women under 45 — and especially under 40, which would indicate premature ovarian insufficiency — blood tests are necessary to confirm the diagnosis and exclude other causes.

What Treatments Have Real Evidence Behind Them

Menopausal Hormone Therapy (MHT): MHT — previously called Hormone Replacement Therapy or HRT — remains the most effective treatment for menopausal symptoms, particularly vasomotor symptoms and genitourinary syndrome. It also provides meaningful bone protection.

The evidence base for MHT has been substantially reassessed since the Women's Health Initiative study findings of the early 2000s generated widespread concern. The current consensus from the British Menopause Society, the International Menopause Society, and other major bodies is clear: for healthy women under 60, or within 10 years of menopause, the benefits of MHT for symptom management generally outweigh the risks in the absence of specific contraindications. Risk profiles vary significantly depending on the formulation, the route of administration (oral versus transdermal — patch or gel), and individual history.

If you have been told simply that "HRT is too risky" without a specific explanation of your personal risk factors, that conversation deserves to be revisited with more detail.

Local vaginal oestrogen: For genitourinary symptoms specifically, low-dose vaginal oestrogen (cream, pessary, or ring) is highly effective and carries minimal systemic absorption — it is considered safe even for women who cannot take systemic MHT, including most women with a history of hormone-sensitive breast cancer who are experiencing significant vaginal symptoms.

Non-hormonal options: For women who cannot or choose not to use MHT, SSRIs and SNRIs — most commonly used as antidepressants — have demonstrated efficacy in reducing the frequency and severity of hot flushes. Cognitive Behavioural Therapy has good evidence for improving sleep and mood during the menopausal transition. A newer medication called fezolinetant, a neurokinin B receptor antagonist, works directly on the brain's temperature regulation without using hormones and has shown promising results in clinical trials.

Lifestyle foundations: Regular weight-bearing and resistance exercise slows bone loss and improves mood and sleep. Calcium and vitamin D supplementation is appropriate for the majority of Indian women in this life stage. Reducing caffeine and alcohol may lessen vasomotor symptoms for some women.

After Menopause: What to Monitor

Bone density assessment (a DEXA scan) is recommended for women with risk factors for osteoporosis and routinely after 65. Cardiovascular risk should be reassessed, as the lipid profile often shifts unfavourably after oestrogen withdrawal. These are conversations to have proactively — not after a fracture or a cardiovascular event.

Menopause is not a disease. It is a normal biological transition that every woman who lives long enough will go through. But "normal" does not mean you have to manage a decade of disruptive symptoms without support. The gap between what is clinically available and what women in India are actually offered or know to ask for remains wide.

If you are experiencing symptoms that feel perimenopausal, or if you have been through menopause and are dealing with ongoing issues, a proper evaluation can make a genuine difference. You are welcome to complete a Smart Consultation for a personalised assessment of where you are in this transition and what options are appropriate for you.